https://www.indianpharmapost.com/aarti-drugs-q3-fy23-revenue-grows-4-136542023-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-inspection-zydus-lifesciences-and-gland-pharma-136552023-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-laboratories-launches-difluprednate-ophthalmic-emulsion-005-in-us-136562023-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-provides-exception-to-glenmarks-baddi-facility-136572023-01-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/bliss-gvs-pharma-posts-q3-fy23-consolidated-pat-at-rs-2794-cr-136582023-01-28T00:00:00+05:30always0.9